Excellent paper on the poor quality of clinical trials for ADHD medications. Low numbers, short durations.... https://t.co/XOAcztOaou
RT @bmdurg: ADHDに使用される小児精神薬は、効果も安全性も確認されないまま承認されている、とボストンの研究者 https://t.co/SVVQm2ojcQ
ADHDに使用される小児精神薬は、効果も安全性も確認されないまま承認されている、とボストンの研究者 https://t.co/SVVQm2ojcQ
RT @mandl: ADHD dx rates surge, https://t.co/hXP02hr0l4 but meds used to treat were tested in small, short studies. https://t.co/j5nRccqbiJ…
ADHD dx rates surge, https://t.co/hXP02hr0l4 but meds used to treat were tested in small, short studies. https://t.co/j5nRccqbiJ @bos_chip
@AutismOne "...according to a new study by Boston Children’s Hospital researchers." LINK: http://t.co/xnaYdQYo5W
Premarket Safety and Efficacy Studies for ADHD Medications in Children http://t.co/nrs5Yu2rWF
Premarket Safety and Efficacy Studies for ADHD Medications in Children http://t.co/yRJPBS8wfS
Clinical trials of many #ADHD drugs not designed to assess rare adverse events or long-term safety and efficacy. http://t.co/Ap7JKU0fRF
Little or no evidence for conventional Rx for ADD/ADHD according to major medical journal: http://t.co/yUW2dnaPjS
@GlennBeck@patandstu How safe r the FDA approved Psych drugs that people r taking? Does science really back them up? http://t.co/JspSfy0MkV
Little or no evidence for conventional Rx for ADD/ADHD according to major medical journal: http://t.co/yUW2dnaPjS
Little or no evidence for conventional Rx for ADD/ADHD according to major medical journal: http://t.co/yUW2dnaPjS
Premarket Safety and Efficacy Studies for #ADHD Medications in #Children http://t.co/cEGgy7ZvbJ de @PLOSONE comentado en @SaludyFarmacos
Premarket Safety and Efficacy Studies for #ADHD Medications in #Children http://t.co/cEGgy7ZvbJ de @PLOSONE comentado en @SaludyFarmacos
#FDA's approval of #ADHD drug of the #pharmaceutical companies are often random #research #shows. #coe #UN #forskning.http://t.co/hdERqFCMwE
Review #ADHD drug approvals highlights gaps between approval process,long-term safety #assessment @coe @PompidouGroup http://t.co/hdERqFCMwE
Clinical trials conducted for the approval #ADHD drugs have not been designed to assess long-term safety and efficacy http://t.co/XHpCAWyVst
Clinical trials conducted for the approval #ADHD drugs have not been designed to assess long-term safety and efficacy http://t.co/XHpCAWyVst
Clinical trials conducted for the approval #ADHD drugs have not been designed to assess long-term safety and efficacy http://t.co/XHpCAWyVst
Clinical trials conducted for the approval #ADHD drugs have not been designed to assess long-term safety and efficacy http://t.co/XHpCAWyVst
Veiligheid ADHD medicatie op lange termijn onvoldoende onderzocht; http://t.co/ZYOMDUfuTn
An interesting paper on the premarket safety studies for ADHD medication in the US: http://t.co/MlS1kIriKR
ADHD-MEDICATIE | Overzichtsstudie: de geneesmiddelen zijn niet getest op veiligheid en werkzaamheid op lange termijn: http://t.co/PbWUgc1rZH
ADHD-MEDICATIE | Overzichtsstudie: de geneesmiddelen zijn niet getest op veiligheid en werkzaamheid op lange termijn: http://t.co/PbWUgc1rZH
Premarket Safety and Efficacy Studies for ADHD Medications in Children http://t.co/xU3c3M6kWh [Trials weren't designed to catch rare events]
PLoS ONE。変わった切り口の論文。ADHD治療薬の承認までに行われた臨床試験の参加者数や投薬期間をまとめている。本来は長期投与の安全性を確かめてから、承認したいところなんだろうけど……。 / “PLOS ONE: Prema…” http://t.co/umO4qs8BWR
PLoS ONE。変わった切り口の論文。ADHD治療薬の承認までに行われた臨床試験の参加者数や投薬期間をまとめている。本来は長期投与の安全性を確かめてから、承認したいところなんだろうけど……。 / “PLOS ONE: Prema…” http://t.co/umO4qs8BWR
Premarket Safety & Efficacy Studies for #ADHD Medications in Children http://t.co/YlZDYG9X0s RCTs don't assess long-term safety and efficacy
#PLOSONE: Premarket Safety and Efficacy Studies for ADHD Medications in Children http://t.co/a6fZCfM32B
ADHD治療薬が市場に流通する前に実施された臨床試験の被験者の人数は75人(中央値)。臨床試験の実施期間の中央値は4週間。Premarket Safety and Efficacy Studies for ADHD … http://t.co/zTySbpEYUz
Premarket Safety and Efficacy Studies for ADHD Medications in Children http://t.co/SzVC1mWbGX
Trials for ADHD drugs not designed to assess rare adverse events or long-term safety and efficacy. http://t.co/qfyTSN8xwV